glp 1 agonist in heart failure The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Glucagon-like peptide 1(GLP-1) receptor agonists
Description
The American Heart Association's Heart Disease and Stroke Statistics report has documented significant racial disparities in comorbidity management outcomes and healthcare delivery [116]
Espinosa, Enith
Within the growing diabetes and obesity sectors, GLP-1 therapies are expanding at a compound annual growth rate of nearly 20%
46,47 Thus, we fed ob/ob mice with the GAN diet to construct the NSAH model in the present study
& Pan, Q
By combining semaglutide with cagrilintide (an amylin receptor agonist), this therapy has delivered weight loss results exceeding 20% in clinical trials
